UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000049296
Receipt number R000056146
Scientific Title Analysis of multidisciplinary treatment using chemotherapy, carbon ion therapy, and surgery for stage II and III esophageal cancer
Date of disclosure of the study information 2022/11/01
Last modified on 2023/11/10 08:23:52

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Analysis of multidisciplinary treatment using chemotherapy, carbon ion therapy, and surgery for stage II and III esophageal cancer

Acronym

Analysis of multidisciplinary treatment using chemotherapy, carbon ion therapy, and surgery for stage II and III esophageal cancer

Scientific Title

Analysis of multidisciplinary treatment using chemotherapy, carbon ion therapy, and surgery for stage II and III esophageal cancer

Scientific Title:Acronym

Analysis of multidisciplinary treatment using chemotherapy, carbon ion therapy, and surgery for stage II and III esophageal cancer

Region

Japan


Condition

Condition

Stage II and III esophageal cancer

Classification by specialty

Gastroenterology Gastrointestinal surgery Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To investigate the usefulness and safety of multidisciplinary treatment of chemotherapy, carbon ion therapy, and surgery for stage II and III esophageal cancer.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Adverse reactions in normal tissues

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

75 years-old >=

Gender

Male and Female

Key inclusion criteria

(1) Histologically confirmed thoracic esophageal squamous cell carcinoma.
(2) The clinical stage is II or III.
(3) Lesions for which therapeutic effects can be evaluated by endoscopy.
(4) Age is between 20 and 75 years old. Gender does not matter.
(5) PS (EROG) is 0 or 1.
(6) Radical treatment for esophageal cancer is possible.
(7) No history of treatment for esophageal cancer.
(8) The functions of major organs are maintained.
(9) Written informed consent has been obtained from the patient.

Key exclusion criteria

(1) Patients with a history of radiotherapy at the irradiation site.
(2) Active double cancer in other organs.
(3) Active interstitial pneumonia.
(4) Active and intractable infection in the planned irradiation area.
(5) HBs antigen, HCV antibody. HIV antibody and HTLV antibody positive.
(6) Cases judged inappropriate by the principal investigator

Target sample size

27


Research contact person

Name of lead principal investigator

1st name Tetsuro
Middle name
Last name Isozaki

Organization

National Institutes for Quantum Sciences and Technology QST Hospital

Division name

Department of radiology

Zip code

263-8555

Address

4-9-1, anagawa, inage-ku,chiba. japan

TEL

043-206-3306

Email

isozaki.tetsuro@qst.go.jp


Public contact

Name of contact person

1st name Tetsuro
Middle name
Last name Isozaki

Organization

National Institutes for Quantum Sciences and Technology QST Hospital

Division name

Department of radiology

Zip code

263-8555

Address

4-9-1, anagawa, inage-ku,chiba. japan

TEL

043-206-3306

Homepage URL


Email

isozaki.tetsuro@qst.go.jp


Sponsor or person

Institute

National Institutes for Quantum Sciences and Technology QST Hospital

Institute

Department

Personal name



Funding Source

Organization

National Institutes for Quantum Sciences and Technology QST Hospital

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor

Department of frontier surgery Graduate school of medicine, Chiba University

Name of secondary funder(s)



IRB Contact (For public release)

Organization

National Institutes for Quantum Sciences and Technology QST Hospital

Address

4-9-1, anagawa, inage-ku,chiba. japan

Tel

043-206-3306

Email

isozaki.tetsuro@qst.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 11 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2022 Year 11 Month 01 Day

Date of IRB

2022 Year 10 Month 13 Day

Anticipated trial start date

2022 Year 11 Month 01 Day

Last follow-up date

2023 Year 11 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Data will be extracted from electronic medical records and other medical information processed in such a way that specific individuals cannot be identified unless the data is cross-checked with other information. Data from both Chiba University Hospital and QST Hospital will be shared for analysis.


Management information

Registered date

2022 Year 10 Month 24 Day

Last modified on

2023 Year 11 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000056146


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name